With delayed trials carrying a significant cost burden, poor execution at the point of care is a liability no AI discovery tool can fix.
Richard Graham, PhD
Advertisement
Richard Graham, PhD, Chairman and Co-Founder, TruTechnologies, Durham, NC.
Articles by Richard Graham, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5